Effect of Adherence to the First-Generation Injectable Immunomodulatory Drugs on Disability Accumulation in Multiple Sclerosis: A Longitudinal Cohort Study

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2017-018612
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Change in Disability Profile and Quality of Life in Multiple Sclerosis Patients: A Five-Year Longitudinal Study Using the Multiple Sclerosis Impact Profile (MSIP)

Multiple Sclerosis
Neurology
2011English

New Multiple Sclerosis Disease Severity Scale Predicts Future Accumulation of Disability

Frontiers in Neurology
Neurology
2017English

The Effect of Second-Generation Antipsychotics on Hippocampal Volume in First Episode of Psychosis: Longitudinal Study

BJPsych Open
PsychiatryMental Health
2016English

The Association of Adherence to Disease-Modifying Drugs and Out-Of-Pocket Costs in Patients With Multiple Sclerosis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Cereblon: A Protein Crucial to the Multiple Functions of Immunomodulatory Drugs as Well as Cell Metabolism and Disease Generation

Journal of Immunology Research
MedicineAllergyImmunology
2017English

The First 10 Years With Multiple Sclerosis: The Longitudinal Course of Daily Functioning

Journal of Rehabilitation Medicine
MedicinePhysical TherapySports TherapyRehabilitationSports Science
2013English

Relevance of Spinal Cord Abnormalities to Clinical Disability in Multiple Sclerosis: MR Imaging Findings in a Large Cohort of Patients

Radiology
Nuclear MedicineRadiologyImaging
2013English

Evaluation of the Adherence to Immunmodulatory Treatment in Patients With Multiple Sclerosis

Noropsikiyatri Arsivi
PsychiatryNeuroscienceMental Health
2015English

Biomarkers and Disease Activity in Multiple Sclerosis : A Cohort Study on Patients With Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis

Linköping University Medical Dissertations
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy